Essa Shares Plummet as Merger Terms Are Slashed
Published on 09/27/2025 at 08:09 | Redaktion boerse-global.de
Investors in Essa have reacted harshly to a severe downgrade in the proposed terms for its business combination with XenoTherapeutics. The announcement has triggered a significant sell-off, eroding shareholder confidence and driving the stock price sharply lower.
The negative sentiment was immediately reflected in the market. Essa’s stock tumbled nearly 9.69% over the past 24-hour period, bringing its weekly loss to approximately 7.26%. The most dramatic move occurred in pre-market trading following the news, where shares plummeted by 17%, indicating a decisive punitive response from the investment community.
Drastic Reduction in Shareholder Payouts
The core issue lies in the radically altered conditions of the merger. Shareholders are now set to receive a cash dividend of just $0.12 per share,... Read more...
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
